Chemours Q3 Adjusted EPS $0.21 vs. IBES Estimate $0.27
Chemours reported Q3 adjusted net income of $31 million versus an IBES estimate of $43.2 million.
Chemours reported Q3 adjusted net income of $31 million versus an IBES estimate of $43.2 million.